<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <ref-type name="Journal Article">17</ref-type>
      <contributors>
        <authors>
          <author>Amna Rashid</author>
          <author>Rameen Matloob</author>
          <author>Khalid Rauf</author>
          <author>Muhammad Hassham Hassan Bin Asad</author>
          <author>Zia Uddin</author>
          <author>Nabi Shah</author>
          <author>Ikram Ullah Khan</author>
          <author>Muhammad Ikram</author>
        </authors>
      </contributors>
      <titles>
        <title>ROSMARINIC ACID MITIGATES RADIATION-INDUCED THYMIC AND SPLENIC INJURY THROUGH ANTIOXIDANT ENHANCEMENT AND MODULATION OF THYMIC mRNA EXPRESSION IN MICE</title>
        <secondary-title>Journal of Animal and Plant Sciences</secondary-title>
        <alt-title>JAPS</alt-title>
      </titles>
      <dates><year>2027</year><pub-dates><date>2027</date></pub-dates></dates>
      <volume>37</volume>
      <number>1</number>
      <isbn>1018-7081</isbn>
      <electronic-resource-num>https://doi.org/10.36899/JAPS.2027.1.0013</electronic-resource-num>
      <abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;Ionizing radiation causes significant harm to lymphoid organs through oxidative stress, cellular depletion, and disruption of tissue architecture. The study aimed to establish a sublethal&amp;nbsp;&lt;sup&gt;137&lt;/sup&gt;Cs &amp;gamma;-radiation-induced model of thymic and splenic injury and to evaluate the mitigating effects of rosmarinic Acid (RA). Total 144 BALB/c mice, 6-8 weeks age and 18-22 g weight, were randomly allocated into six groups: normal control, irradiated control, RA50, RA100, RA150, and levamisole. Mice were exposed to&amp;nbsp;&lt;sup&gt;137&lt;/sup&gt;Cs &amp;gamma;-radiation to induce thymic and splenic injury and were subsequently treated with RA at doses of 50, 100, 150 mg/kg for 14 days. The mitigating effects of RA were assessed using hematological parameters, thymic and splenic indices, organ cellularity, histological architecture, oxidative-stress and antioxidant markers, and the thymic expression of FoxN1, IL-6, IL-7, and IL-15. At 150 mg/kg dose, thymus and spleen index increased significantly (p &amp;le; 0.001) from irradiated group. Histological examination showed reduced radiation-associated hypocellularity and architectural disruption in the thymus and spleen, improvement observed at 150 mg/kg. RA significantly reduced malondialdehyde levels in the thymus and spleen (p &amp;le; 0.001) than irradiated group following treatment with 150mg/kg and significantly improved SOD (p &amp;le; 0.001), GPx (p &amp;le; 0.001), CAT (p &amp;le; 0.01) activity. Furthermore, RA significantly modulated the radiation-altered expression of IL-7 (p &amp;le; 0.001), IL-6, IL-15, and FoxN1 (p &amp;le; 0.01) mRNA in the thymus, at 150 mg/kg. Overall, RA, mitigated sublethal radiation-associated thymic and splenic injury, as demonstrated by improvements in hematological and organ indices, oxidative-stress and antioxidant markers, lymphoid tissue architecture, and thymic mRNA expression. These findings suggest that RA may have potential as a natural immunomodulatory agent against radiation-associated lymphoid injury.&lt;/p&gt;</abstract>
      <keywords><keyword>Thymus, Radiation, Rosmarinic acid, Cytokines, Antioxidant</keyword></keywords>
      <publisher>Pakistan Agricultural Scientists Forum</publisher>
      <urls><related-urls><url>https://thejaps.org.pk/AbstractView.aspx?mid=2026-JAPS-648</url></related-urls></urls>
    </record>
  </records>
</xml>
